Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CAS 161796 78 7. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102887885A details a high-purity Esomeprazole Sodium synthesis via inclusion complex resolution, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Advanced mixed solvent recrystallization for Esomeprazole Sodium ensures high purity and yield. Ideal for pharmaceutical intermediates supply chain optimization and cost reduction.
Patent CN112661744B reveals an isothermal purification method for Esomeprazole Sodium, achieving >99.5% purity with minimal R-enantiomer. Ideal for reliable pharmaceutical intermediate supply chains.